SCHEMBL7647520

SCHEMBL7647520

O=C(O)CCC(C(=O)O)C(c1cccc2[nH]ccc12)[PH](=O)O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 4/20 0.35
HDAC2 Q92769 4/20 0.35
HDAC3 O15379 3/20 0.35
HDAC4 P56524 3/20 0.35
HDAC7 Q8WUI4 3/20 0.35
HDAC10 Q969S8 3/20 0.35
HDAC11 Q96DB2 3/20 0.35
HDAC8 Q9BY41 3/20 0.35
HDAC6 Q9UBN7 3/20 0.35
HDAC9 Q9UKV0 3/20 0.35
HDAC5 Q9UQL6 3/20 0.35
PARP1 P09874 1/20 0.34
ADAM17 P78536 1/20 0.33
GLS O94925 1/20 0.33
MEN1 O00255 1/20 0.33
MAPT P10636 1/20 0.33
PKM P14618 1/20 0.33
KMT2A Q03164 1/20 0.33
HPGDS O60760 1/20 0.32
MAPK14 Q16539 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7654118 0.84 HDAC3 (0.48) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL7647791 0.80 CYP2C19 (0.42)
SCHEMBL8459378 0.77 HPGDS (0.41) MEN1MAPTPKMKMT2AHPGDS
SCHEMBL7653130 0.71 PARP1 (0.34) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL7647686 0.70 CCKBR (0.39) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL5058001 0.70 HDAC1 (0.35) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL29966571 0.68 PTGS2 (0.42) MAPT
SCHEMBL6099297 0.68 PTGS2 (0.42) MAPT
SCHEMBL6563314 0.67 MCL1 (0.40) MEN1MAPTPKMKMT2AHPGDS
SCHEMBL29966351 0.67 MAPT (0.45) MEN1MAPTPKMKMT2AHPGDS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2002515040-A 2002-05-21 JP claimed
EP-0954295-A1 METHODS OF CANCER TREATMENT USING NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1999-11-10 EP claimed
WO-1997048409-A1 METHODS OF CANCER TREATMENT USING NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1997-12-24 WO claimed